在银色海中溺水:老年患者比例对创伤结果的影响
Sebastian Boland1, Liling Lu2, Tamara Byrd1
1Division of Trauma and General Surgery, Department of Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA.
Surgery
|September 15, 2025
概括
当老年患者的比例超过65%时,所有患者的创伤中心结果都会恶化. 高老年患者数量可能会压倒创伤中心,影响老年人和非老年患者的死亡率.
科学领域:
- 创伤外科 手术 创伤外科
- 老年医学 老年医学
- 医疗保健服务研究 医疗服务研究
背景情况:
- 在创伤护理中建立的体积-结果关系对于老年患者来说是复杂的.
- 越来越多的老年人群提出了关于创伤中心容量的潜在临界点的问题.
- 了解老年患者比例对结果的影响对于创伤系统规划至关重要.
研究的目的:
- 评估老年患者与创伤总体相比的比例是否会影响患者的治疗结果.
- 确定老年患者体积可能对创伤中心性能产生负面影响的潜在门.
- 分析老年患者比例对死亡率的非线性影响.
主要方法:
- 从2017-2021年对成人创伤患者 (>15岁) 的回顾性队列研究.
- 在总成年患者体积中计算中心水平的年老年人比例.
- 用于评估老年人比例和死亡率之间的非线性关系的一般化添加混合模型,经过调整以考虑混因素.
主要成果:
- 增加老年人比例改善了老年患者的死亡率,达到总体量的65%,之后趋于平稳.
- 非老年患者的死亡率开始增加,老年患者的比例为61%.
- 更高的老年患者比例与非老年患者死亡率的增加有关,特别是考虑到老年伴随性疾病时.
结论:
- 中心水平的老年患者比例显著预测了老年患者和非老年患者的创伤结果.
- 高的老年人比例可能表明中心被压倒,导致体积-结果效益下降,所有人的死亡率增加.
- 这些发现支持创伤系统规划,以优化对不同患者群体的护理.
相关概念视频
Drug Dosing: Geriatric Patients
228
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
228
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
232
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
232
Pharmacodynamics in Geriatric Patients: Effects of Age
188
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
188
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
229
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
229
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
197
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
197
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
238
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
238


